Loading...

Invitae Corporation

NVTANYSE
Healthcare
Medical - Diagnostics & Research
$0.02
$-0.01(-35.59%)

Invitae Corporation (NVTA) Company Profile & Overview

Explore Invitae Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Invitae Corporation (NVTA) Company Profile & Overview

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOMr. Kenneth D. Knight

Contact Information

415 374 7782
1400 16th Street, San Francisco, CA, 94103

Company Facts

1,700 Employees
IPO DateFeb 12, 2015
CountryUS

Frequently Asked Questions